Feature | Specification |
---|---|
Application | Protein Quantification |
Sample Volume | 5 µL |
The CD32b (FcgRIIb) cellular binding assay is a simple and robust test to monitor binding of the IgG Fc region to the human CD32b receptor in live cells. The CD32b receptor negatively modulates the Antibody-Dependent Cell-Phagocytosis (ADCP) pathway. This assay, based on our innovative Tag-lite technology, can easily be automated to create a high-throughput solution for predicting ADCP.
The CD32b receptor cellular binding assay is a competitive assay involving HEK293 cells expressing a specific CD32b variant conjugated to Lumi4-terbium Cryptate, and human IgG1 labelled with d2. The unlabeled antibody or Fc tagged drug competes with the d2 labelled IgG1 for binding to the receptor, resulting in a decrease of FRET signal.
The CD32b receptor cellular binding assays (FcgIIb) present only 1 incubation step after reagents distribution. Lumi4-terbium Cryptate pre-labelled cells are dispensed, followed by the addition of IgG1 labelled with d2 and the sample. After 2h incubation at RT, the signal can be read.
Application |
Protein Quantification
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Product Group |
Kit
|
Sample Volume |
5 µL
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Biologics
|
Technology |
TR-FRET
|
Therapeutic Area |
Cardiovascular
Infectious Diseases
Metabolism/Diabetes
NASH/Fibrosis
Neuroscience
Rare Diseases
|
Unit Size |
100 assay points
|
Are you looking for resources, click on the resource type to explore further.
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
This guide provides you an overview of HTRF applications in several therapeutic areas.
We are here to answer your questions.